✦ LIBER ✦

PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression: Cost-Utility and Cost-Effectiveness Analysis

✍ Scribed by J. Walczak; M. Garbacka; J. Zawieja; P. Prząda-Machno; J. Kroc

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN63 Cost-Effectiveness of Sunitinib in

✍ Soares, M.; Inês, M.; Contente, M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of everolimus vs suni

✍ Casciano, Roman; Chulikavit, Maruit; Perrin, Allison; Liu, Zhimei; Wang, Xufang; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 425 KB

Cost-Effectiveness and Cost-Utility Anal

✍ Gouveia, M.; Borges, M.; Augusto, M.; Costa, J.; Treur, M.; Lopes, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost-effectiveness analysis of sunitinib

✍ Luis Paz-Ares; Xavier García del Muro; Enrique Grande; Paloma González; Max Bros 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 461 KB

Cost-Effectiveness Analysis of Cysteamin

✍ Walczak, J.; Stelmachowski, J.; Obrzut, G.; Hubert, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PRP7: COST-EFFECTIVENESS ANALYSIS OF SEQ

✍ D Gorecka; R Jaworski; M Czech; R Pachocki; S Corcaud 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB